Your browser doesn't support javascript.
loading
Seroprevalence of SARS-CoV-2 Antibodies and Factors Associated with Seropositivity at the University of Salamanca: The DIANCUSAL Study.
Muro, Antonio; Belhassen-García, Moncef; Muñoz Bellido, Juan Luís; Lorenzo Juanes, Helena; Vicente, Belén; Pendones, Josué; Adserias, José; Sánchez Hernández, Gonzalo; Rodríguez Rosa, Miguel; Vicente Villardón, José Luis; Burguillo, Javier; López Andaluz, Javier; Martín Oterino, Jose Angel; García Criado, Francisco Javier; Barbero, Fausto; Morales, Ana Isabel; Galindo Villardón, Purificación; González Sarmiento, Rogelio.
Afiliação
  • Muro A; Infectious and Tropical Diseases Group (e-INTRO), Institute of Biomedical Research of Salamanca-Research Center for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
  • Belhassen-García M; Infectious and Tropical Diseases Group (e-INTRO), Institute of Biomedical Research of Salamanca-Research Center for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
  • Muñoz Bellido JL; Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Lorenzo Juanes H; Microbiology & Parasitology Service, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Vicente B; Department of Biomedical and Diagnostic Sciences, University of Salamanca, 37008 Salamanca, Spain.
  • Pendones J; Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Adserias J; Microbiology & Parasitology Service, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Sánchez Hernández G; Department of Biomedical and Diagnostic Sciences, University of Salamanca, 37008 Salamanca, Spain.
  • Rodríguez Rosa M; Infectious and Tropical Diseases Group (e-INTRO), Institute of Biomedical Research of Salamanca-Research Center for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
  • Vicente Villardón JL; Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • Burguillo J; Microbiology & Parasitology Service, University Hospital of Salamanca, 37007 Salamanca, Spain.
  • López Andaluz J; Department of Biomedical and Diagnostic Sciences, University of Salamanca, 37008 Salamanca, Spain.
  • Martín Oterino JA; IT Department, University of Salamanca Foundation (FGUSAL), University of Salamanca, 37008 Salamanca, Spain.
  • García Criado FJ; Data Processing Center (CPD), University of Salamanca, 37008 Salamanca, Spain.
  • Barbero F; Department of Statistics, University of Salamanca, 37008 Salamanca, Spain.
  • Morales AI; Department of Statistics, University of Salamanca, 37008 Salamanca, Spain.
  • Galindo Villardón P; Department of Chemistry-Physics, Faculty of Pharmacy, University of Salamanca, 37008 Salamanca, Spain.
  • González Sarmiento R; Department of Nursing and Phisiotherapy, University of Salamanca, 37008 Salamanca, Spain.
  • On Behalf Of The Diancusal Team; Institute of Biomedical Research of Salamanca (IBSAL), University of Salamanca, University Hospital of Salamanca, 37007 Salamanca, Spain.
J Clin Med ; 10(15)2021 Jul 21.
Article em En | MEDLINE | ID: mdl-34361998
ABSTRACT

BACKGROUND:

Systematic screening for antibodies against SARS-CoV-2 is a crucial tool for surveillance of the COVID-19 pandemic. The University of Salamanca (USAL) in Spain designed a project called "DIANCUSAL" (Diagnosis of New Coronavirus, COVID-19, in University of Salamanca) to measure antibodies against SARS-CoV-2 among its ~34,000 students and academic staff, as the influence of the university community in the spread of the SARS-CoV-2 pandemic in the city of Salamanca and neighboring towns hosting USAL campuses could be substantial.

OBJECTIVE:

The aim of this study was to estimate the prevalence of SARS-CoV-2 antibodies among USAL students, professors and staff and to evaluate the demographic, academic, clinical and lifestyle and behavioral factors related to seropositivity.

METHODOLOGY:

The DIANCUSAL study is an ongoing university population-based cross-sectional study, with the work described herein conducted from July-October 2020. All USAL students, professors and staff were invited to complete an anonymized questionnaire. Seroprevalence of anti-SARS-CoV-2 antibodies was detected and quantified by using chemiluminescent assays for IgG and IgM. PRINCIPAL

FINDINGS:

A total of 8197 (24.71%) participants were included. The mean age was 31.4 (14.5 SD) years, and 66.0% of the participants were female. The seroprevalence was 8.25% overall and was highest for students from the education campus (12.5%) and professors from the biomedical campus (12.6%), with significant differences among faculties (p = 0.006). Based on the questionnaire, loss of smell and fever were the symptoms most strongly associated with seropositivity, and 22.6% of seropositive participants were asymptomatic. Social distancing was the most effective hygiene measure (p = 0.0007). There were significant differences in seroprevalence between participants with and without household exposure to SARS-CoV-2 (p = 0.0000), but not between students who lived in private homes and those who lived in dormitories. IgG antibodies decreased over time in the participants with confirmed self-reported COVID-19 diagnoses.

CONCLUSIONS:

The analysis revealed an overall 8.25% seroprevalence at the end of October 2020, with a higher seroprevalence in students than in staff. Thus, there is no need for tailored measures for the USAL community as the official average seroprevalence in the area was similar (7.8% at 22 June and 12.4 at 15 November of 2020). Instead, USAL members should comply with public health measures.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Observational_studies / Risk_factors_studies Idioma: En Revista: J Clin Med Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Espanha